Skip to content

Efficacy of Stage-Matched Intervention in Changing Body Composition Exercise Behavior Among Female Collegians: A Randomized Controlled Trial

Efficacy of Stage-Matched Intervention in Changing Body Composition Exercise Behavior Among Female Collegians: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250407065245N1
Enrollment
144
Registered
2025-05-29
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not a disease. N/A

Interventions

Intervention 1: Intervention group: Before beginning the body composition exercise, participants will complete a questionnaire to assess their current stage. Those in the intervention group will then

Sponsors

University of Baghdad
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 24 Years

Inclusion criteria

Inclusion criteria: Female college students aged between 18 and 25 years. Enrolled full-time at a university or college. Able to provide informed consent. Classified in the precontemplation, contemplation, preparation, or action stages of the Transtheoretical Model (TTM) for exercise behavior. Not currently engaged in regular structured exercise (i.e., less than 150 minutes of moderate-intensity exercise per week). Available and willing to participate in all intervention sessions and assessments over the study duration.

Exclusion criteria

Exclusion criteria: Diagnosed with medical conditions that contraindicate physical activity (e.g., cardiovascular disease, severe asthma, musculoskeletal disorders). Currently pregnant or planning to become pregnant during the study period. Participation in another weight management or exercise program within the past 3 months. Use of medications that significantly affect weight or metabolism (e.g., corticosteroids, thyroid medications). Presence of a diagnosed eating disorder or severe psychiatric illness. Inability to commit to follow-up assessments (e.g., due to anticipated travel or academic leave).

Design outcomes

Primary

MeasureTime frame
Primary Outcome: Change in exercise behavior. Timepoint: Change in exercise behavior, measured by stages of change Timepoints:•Pre-test (Baseline)•Post-test 1 (3 months after intervention)•Post-test 2 (6 months after baseline). Method of measurement: Body composition will be measured using standardized anthropometric methods and bioelectrical impedance analysis. Exercise behavior will be assessed using a validated physical activity questionnaire. Body Mass Index (BMI) will be calculated accordingly. Waist and hip circumferences will be measured with a non-stretchable tape (e.g., Gulick II Tape Measure) following WHO guidelines.

Secondary

MeasureTime frame
Secondary Outcomes: Change in body composition. Timepoint: Change in body composition, measured by stages of change Timepoints: • Pre-test (Baseline) • Post-test 1 (3 months after intervention) • Post-test 2 (6 months after baseline). Method of measurement: Anthropometry: Weight (digital scale), height (stadiometer), BMI calculation. Validated self-report questionnaires based on the Transtheoretical Model (TTM) of behavior change (e.g., Exercise Self-Efficacy Scale, Decisional Balance Scale, and Processes of Change Questionnaire).

Countries

Iraq

Contacts

Public ContactDarya Sobhi Ramadan

University of Baghdad

deria.sobhi1206a@conursing.uobaghdad.edu.iq+964 771 944 1864

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026